Journal article

Thrombolysis and Thrombectomy for Acute Ischemic Stroke: Strengths and Synergies

Bruce CV Campbell

SEMINARS IN THROMBOSIS AND HEMOSTASIS | THIEME MEDICAL PUBL INC | Published : 2017

Abstract

Acute ischemic stroke is responsible for around 80% of all strokes and is a leading cause of disability and death globally. There are two potential treatment strategies: restoring blood flow (reperfusion) and preventing cellular injury (neuroprotection). As yet, all the successful trials have involved reperfusion with numerous failures of neuroprotectants. There are two proven reperfusion strategies. Intravenous thrombolysis with alteplase was first demonstrated to reduce disability with publication of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator trial in 1995. Since that time further trials have solidified the evidence base and demonstrated benefi..

View full abstract